APA-referens

Hammer, M. D., Schwamm, L., Starkman, S., Schellinger, P. D., Jovin, T., Nogueira, R., . . . Liebeskind, D. S. (2012). Safety and feasibility of NeuroFlo use in eight- to 24-hour ischemic stroke patients.

Chicago-stil citat

Hammer, M. D., et al. Safety and Feasibility of NeuroFlo Use in Eight- to 24-hour Ischemic Stroke Patients. 2012.

MLA-referens

Hammer, M. D., et al. Safety and Feasibility of NeuroFlo Use in Eight- to 24-hour Ischemic Stroke Patients. 2012.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.